Protalix BioTherapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2011
Total Assets: $51.8M
Liabilities Breakdown FY2011
Total Liabilities: $77.9M
Asset Breakdown
Total Assets: $51.8M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $27.0M | 52.1% |
| Accounts Receivable | $1.4M | 2.7% |
| Inventory | $279.0K | 0.5% |
| Property, Plant & Equipment | $18.3M | 35.3% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $4.9M | 9.4% |
Liabilities Breakdown
Total Liabilities: $77.9M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $5.0M | 6.5% |
| Long-Term Debt | $6.6M | 8.4% |
| Other Liabilities | $66.3M | 85.1% |